-Aegerion Pharmaceuticals Inc Awarded Fda's Orphan Drug Designation for Lomitapide for Fc

M2 EquityBites › March 16, 2011

Linked as:

Summary

M2 EQUITYBITES-March 16, 2011-Aegerion Pharmaceuticals Inc awarded FDA's orphan drug designation for lomitapide for FC

(C)1994-2011 M2 COMMUNICATIONS http://www.m2.com

See the full content of this document

Extract

-Aegerion Pharmaceuticals Inc Awarded Fda's Orphan Drug Designation for Lomitapide for Fc

Biopharmaceutical company Aegerion Pharmaceuticals Inc ...

See the full content of this document

Sponsored links

ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Language

Contents in vLex United Kingdom

Explore vLex

For Professionals

For Partners

Company

Other documents:

Electric Car has the Spark Electric Cars Have Been Hitting the Headlines This Week But the Question On Everyone s Lips Is How Good Are Th... | have we seen that look somewhere before, zara? [scot region] | Ephraim Hardcastle | deal in sight as paul and heather give peace a chance | Commentary: Charitable Giving: Helping Workers Retool for Growth Sectors | latinas honradas en evento de hispanidad | aerovironment. | hampshire companies.